MultiCell Technologies, Inc. has added Scott Lukeman, Ph.D., to its board of directors. He has over 25 years of international experience across multiple life-science disciplines in management, strategic planning, business and technology valuation and development, marketing, licensing, fund-raising and competitive intelligence.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -90.00% | 0.00% | 0.00% |
2015 | MultiCell Technologies, Inc. Auditor Raises 'Going Concern' Doubt | CI |
2014 | MultiCell Technologies Files Novel Antibody-Drug Conjugate Patent Application | CI |
1st Jan change | Capi. | |
---|---|---|
0.00% | 5K | |
+26.55% | 44.96B | |
+0.13% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+10.16% | 26.08B | |
-20.96% | 19.03B | |
+6.64% | 12.75B | |
+28.71% | 12.06B | |
-3.95% | 11.75B |
- Stock Market
- Equities
- MCET Stock
- News MultiCell Technologies, Inc.
- MultiCell Technologies, Inc. Adds Scott Lukeman to its Board of Directors